|
[1] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
|
[2]NING L, LIN W, HU X, et al.Prevalence of chronic kidney disease in patients with chronic hepatitis B:a cross-sectional survey[J].J Viral Hepat, 2017, 24 (11) :1043-1051.
|
|
[3]CHOLONGITAS E, TZIOMALOS K, PIPILI C.Management of patients with hepatitis B in special populations[J].World J Gastroenterology, 2015, 21 (6) :1738-1748.
|
|
[4]European Association for the Study of the Liver.EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection[J].J Hepatol, 2017, 67 (2) :370-398.
|
|
[5]TERRAULT NA, BZOWEJ NH, CHANG NH, et al.AASLDguidelines for treatment of chronic hepatitis B[J].Hepatology, 2016, 63 (1) :261-283.
|
|
[6]PERRILLO RP.Hepatitis B reactivation from immunosuppressive drug therapy:a global menace[J].Clin Liver Dis, 2015, 5 (2) :39-42.
|
|
[7]SHEN ER, ZHANG H, MA SW.Four conflicts in clinical practice brought by complicated infection with tubercle bacillus and hepatitis B virus[J].Chin Hepatol, 2016, 21 (11) :990-994. (in Chinese) 申恩瑞, 张慧, 马世武.结核菌和乙型肝炎病毒合并感染带来的四个临床矛盾[J].肝脏, 2016, 21 (11) :990-994.
|
|
[8]ZHUANG J, DAI B, WU LJ, et al.Clinical observation of hepatitis B virus carriers after renal transplantation[J].Ogran Transplantation, 2017, 8 (1) :66-72. (in Chinese) 庄杰, 代波, 巫丽娟, 等.乙型肝炎病毒携带者肾移植术后临床观察[J].器官移植, 2017, 8 (1) :66-72.
|
|
[9]TUO Y, ZHENG WL, ZHANG CY.Analysis of hepatitis B infection and hepatitis B vaccination status in patients with maintenance hemodialysis[J].China Med Herald, 2014, 11 (7) :97-99, 103. (in Chinese) 托娅, 郑文利, 张春媛.维持性血液透析患者乙肝病毒感染及乙肝疫苗接种现状分析[J].中国医药导报, 2014, 11 (7) :97-99, 103.
|
|
[10]JIA JD, WEI L, HOU JL, et al.Chinese standards for diagnosis and treatment of liver disease-White paper excerpt[J].J Clin Hepatol, 2014, 30 (3) :197-209. (in Chinese) 贾继东, 魏来, 侯金林, 等.《中国肝病诊疗管理规范》白皮书 (节选) [J].临床肝胆病杂志, 2014, 30 (3) :197-209.
|
|
[11]MORANDO F, ROSI S, FASOLATO S, et al.Severe acute hepatitis B in a treatment-na6ve patient with antiviral drug resistant mutations in the polymerase gene[J].J Med Virol, 2013, 85 (2) :210-213.
|
|
[12]VERHAZ A.Experience with lamivudine treatment for severe acute hepatitis B[J].Srp Arh Celok Lek, 2014, 142 (11-12) :703-707.
|
|
[13]ITO K, YOTSUYANAGI H, YATSUHASHI H, et al.Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults[J].Hepatology, 2014, 59 (1) :89-97.
|
|
[14]STREINU-CERCEL A, SANDULESCU O, STEFAN M, et al.Treatment with lamivudine and entecavir in severe acute hepatitis B[J].Indian J Med Microbiol, 2016, 34 (2) :166-172.
|
|
[15]WIEGAND J, WEDEMEYER H, FRANKE A, et al.Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo:a prospective randomized double-blinded multicentre trial[J].JViral Hepat, 2014, 21 (10) :744-750.
|
|
[16]JINDAL A, KUMAR M, SARIN SK.Management of acute hepatitis B and reactivation of hepatitis B[J].Liver Int, 2013, 33 (Suppl1) :164-175.
|
|
[17]ZHUANG YZ.Issues in the diagnosis and treatment of hepatitis Bvirus-associated glomerulonephritis[J].Chin J Integr Tradit West Nephrol, 2015, 16 (8) :659-662. (in Chinese) 庄永泽.乙型肝炎病毒相关性肾炎的诊治问题[J].中国中西医结合肾病杂志, 2015, 16 (8) :659-662.
|
|
[18]WANG L, YE Z, LIANG H, et al.The combination of tacrolimus and entecavir improves the remission of HBV-associated glomerulonephritis without enhancing viral replication[J].Am J Transl Res, 2016, 8 (3) :1593-1600.
|
|
[19]ZHOU YC, ZOU YQ.Professor ZOU Yanqin on treatment to glomerulonephritis associated with hepatitis B virus[J].J Changchun Univ Chin Med, 2015, 31 (5) :939-940. (in Chinese) 周迎晨, 邹燕勤.邹燕勤教授治疗乙型肝炎病毒相关性肾炎[J].长春中医药大学学报, 2015, 31 (5) :939-940.
|
|
[20]CAI J, FAN X, MOU L, et al.Association of reduced renal function with hepatitis B virus infection and elevated alanine aminotransferase[J].Clin J Am Soc Nephrol, 2012, 7 (10) :1561-1566.
|
|
[21]Chinese Society of Hepatology, Chinese Medical Association.Expert consensus on antiviral therapy for chronic hepatitis B with renal injury or high risk of renal injury[J].J Clin Hepatol, 2016, 32 (12) :2242-2247. (in Chinese) 中华医学会肝病学分会.伴有肾脏损伤及其高危风险的慢性乙型肝炎患者抗病毒治疗专家共识[J].临床肝胆病杂志, 2016, 32 (12) :2242-2247.
|
|
[22]de MATTOSZ, de MATTOS AA, MNDEZ-SNCHEZ N.Hepatorenal syndrome:current concepts related to diagnosis and management[J].Ann Hepatol, 2016, 15 (4) :474-481.
|
|
[23]RUNYON BA, AASLD.Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012[J].Hepatology, 2013, 57 (4) :1651-1653.
|
|
[24]BOYER TD, SANYAL AJ, WONG F, et al.Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1[J].Gastroenterology, 2016, 150 (7) :1579-1589.
|
|
[25]GINS P.Terlipressin for hepatorenal syndrome:ready for prime time[J].Lancet Gastroenterol Hepatol, 2017, 2 (2) :75-76.
|
|
[26]KLOOTWIJK ED, REICHOLD M, UNWIN RJ, et al.Renal Fanconi syndrome:taking a proximal look at the nephron[J].Nephrol Dial Transplant, 2015, 30 (9) :1456-1460.
|
|
[27]LI XJ, JIANG L, ZHANG YY, et al.Clinical features of adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia[J].Chin J Endocrinol Metab, 2014, 30 (1) :47-49. (in Chinese) 李晓静, 蒋玲, 张燕燕, 等.阿德福韦酯相关Fanconi综合征、低磷性骨软化症的临床分析[J].中华内分泌代谢杂志, 2014, 30 (1) :47-49.
|
|
[28]WANG XJ, FU QC, ZANG ZS, et al.Adefovir dipivoxil-related chronic kidney disease manifesting as Fanconi syndrome:an analysis of 15 cases[J].Chin Hepatol, 2014, 19 (7) :475-478. (in Chinese) 王晓今, 傅青春, 臧祖胜, 等.表现为范可尼综合征的阿德福韦酯相关慢性肾脏病15例分析[J].肝脏, 2014, 19 (7) :475-478.
|
|
[29]XU LJ, JIANG Y, LIAO RX, et al.Low-dose adefovir dipivoxil may induce Fanconi syndrome:clinical characteristics and longterm follow-up for Chinese patients[J].Antivir Ther, 2015, 20 (6) :603-611.
|
|
[30]XU SD, SONG ZP, KONG QX, et al.Clinical effect of interferon and thymosin in treatment of refractory nephropathy:a report of 6cases[J].J Clin Pediatr, 1996, 14 (1) :67-68. (in Chinese) 徐树东, 宋芝萍, 孔庆旋, 等.干扰素、胸腺肽治疗难治性肾病6例报告[J].临床儿科杂志, 1996, 14 (1) :67-68.
|
|
[31]MIRANDA-GUARDIOLA F, FERNNDEZ-LLAMA P, BADIAJR, et al.Acute renal failure associated with alpha-interferon therapy for chronic hepatitis B[J].Nephrol Dial Transplant, 1995, 10 (8) :1441-1443.
|
|
[32]ROSTAING L, MODESTO A, BARON E, et al.Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C[J].Nephron, 1996, 74 (3) :512-516.
|
|
[33]WANG X, CHAI HQ, QIN AL.Nephrotic syndrome induced by interferonα:a case report and literature review[J].Suzhou Univ JMed Sci, 2009, 29 (2) :391-392. (in Chinese) 王晓, 柴华旗, 秦爱兰.干扰素α致肾病综合征1例报告及文献复习[J].苏州大学学报:医学版, 2009, 29 (2) :391-392.
|
DownLoad: